These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27021326)

  • 21. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic resistance determinants to fusidic acid and chlorhexidine in variably susceptible staphylococci from dogs.
    Frosini SM; Bond R; Rantala M; Grönthal T; Rankin SC; O'Shea K; Timofte D; Schmidt V; Lindsay J; Loeffler A
    BMC Microbiol; 2019 Apr; 19(1):81. PubMed ID: 31023224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
    Lim KT; Teh CS; Yusof MY; Thong KL
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):112-8. PubMed ID: 24336696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis.
    McLaws F; Chopra I; O'Neill AJ
    J Antimicrob Chemother; 2008 May; 61(5):1040-3. PubMed ID: 18299637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.
    Aubin GG; Bémer P; Guillouzouic A; Launay E; Geffroy L; Touchais S; Corvec S
    Infect Dis (Lond); 2016 Sep; 48(9):699-702. PubMed ID: 27194514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
    Rennie RP
    J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel staphylococcal cassette chromosomal element, SCCfusC, carrying fusC and speG in fusidic acid-resistant methicillin-resistant Staphylococcus aureus.
    Lin YT; Tsai JC; Chen HJ; Hung WC; Hsueh PR; Teng LJ
    Antimicrob Agents Chemother; 2014; 58(2):1224-7. PubMed ID: 24277045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
    Pfaller MA; Castanheira M; Sader HS; Jones RN
    Int J Antimicrob Agents; 2010 Mar; 35(3):282-7. PubMed ID: 20036520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study.
    Osterlund A; Kahlmeter G; Haeggman S; Olsson-Liljequist B;
    Scand J Infect Dis; 2006; 38(5):334-4. PubMed ID: 16724423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing.
    Mason BW; Howard AJ; Magee JT
    J Antimicrob Chemother; 2003 Apr; 51(4):1033-6. PubMed ID: 12654748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic basis of resistance to fusidic acid in staphylococci.
    O'Neill AJ; McLaws F; Kahlmeter G; Henriksen AS; Chopra I
    Antimicrob Agents Chemother; 2007 May; 51(5):1737-40. PubMed ID: 17325218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing resistance to fusidic acid among clinical isolates of MRSA.
    Wang JT; Huang IW; Chang SC; Tan MC; Lai JF; Chen PY; Lauderdale TL
    J Antimicrob Chemother; 2017 Feb; 72(2):616-618. PubMed ID: 27733516
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel fusidic acid resistance determinant, fusF, in Staphylococcus cohnii.
    Chen HJ; Hung WC; Lin YT; Tsai JC; Chiu HC; Hsueh PR; Teng LJ
    J Antimicrob Chemother; 2015 Feb; 70(2):416-9. PubMed ID: 25313205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid.
    O'Neill AJ; Bostock JM; Moita AM; Chopra I
    J Antimicrob Chemother; 2002 Dec; 50(6):839-48. PubMed ID: 12461002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
    Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of
    Ghaith DM; Elnagdy SM; Tharwat NA; Said M
    Infect Dis (Lond); 2019; 51(11-12):878-879. PubMed ID: 31448975
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro activity of CEM-102 (fusidic acid) against prevalent clones and resistant phenotypes of Staphylococcus aureus.
    Sahm DF; Deane J; Pillar CM; Fernandes P
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4535-6. PubMed ID: 23774441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
    Decousser JW; Desroches M; Bourgeois-Nicolaos N; Potier J; Jehl F; Lina G; Cattoir V; Vandenesh F; Doucet-Populaire F;
    Int J Antimicrob Agents; 2015 Dec; 46(6):622-30. PubMed ID: 26453147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
    Norström T; Lannergård J; Hughes D
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4438-46. PubMed ID: 17923494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.